用户名: 密码: 验证码:
人类原发性膝关节骨性关节炎病变软骨全基因组表达与分析
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
原发性膝关节骨性关节炎(KOA)是一种随年龄增长而发生率明显增加的退行性关节疾病,是老年人关节疼痛和致残的主要原因。据世界卫生组织(WHO)统计,骨性关节炎在女性患病率中占第四位。随年龄增大,患病率迅速上升,大于65岁人群中50%以上有骨性关节炎的X线片表现。它的主要改变是关节软骨面的退行性变和继发性的骨质增生。主要表现是关节疼痛和活动不灵活,X线表现关节间隙变窄,软骨下骨质致密,骨小梁断裂,有硬化和囊性变。关节边缘有唇样增生。后期骨端变形,关节面凹凸不平。关节内软骨剥落,骨质碎裂进入关节,形成关节内游离体。
     KOA按病因可分为原发性KOA和继发性KOA。原发性KOA是指用目前所有的检查方法查不出病因的骨关节炎,通常所指的骨关节炎属于这一类;继发性KOA是指在其它各种病因或疾病的基础上,诱发的病变,如创伤、类风湿关节炎、神经及内分泌疾病等。这一类骨关节炎的病变比较局限,不伴发赫伯登结节。反复使关节劳损的人群是患骨关节炎的高危人群,如铸造工人、矿工和公共汽车司机等。但是进行长跑锻炼的人却不是患本病的高危人群。肥胖是造成骨关节炎的主要因素,但目前证据尚不充分。按照部位可分为局灶性KOA和全身性KOA,按照是否有临床症状可分为无症状性KOA和症状性KOA。临床工作中遇到的KOA大多是症状性KOA。主要侵害关节软骨和滑膜组织,导致关节疼痛、畸形和功能障碍,从而影响患者的活动能力。正常情况下,关节之间摩擦力很小不会造成磨损,除非过度使用或损伤。造成骨关节炎的最可能原因是合成软骨成分的异常,如胶原(是一种坚韧的、结缔组织中的纤维蛋白)和粘蛋白(一种产生软骨弹性的物质)的异常。另外,软骨虽然生长旺盛,但是很薄,其表面很容易发生破裂。关节边缘的骨过度生长,形成可以看见和摸到的包块(称为骨赘)。骨赘引起关节面不平,干扰正常关节的功能,引起疼痛。
     该病从关节软骨起病,影响整个关节结构,包括软骨下骨、韧带、滑膜、关节囊及关节外肌肉,最终因关节软骨全部脱失而导致关节畸形和功能丧失的一种疾病。
     关节软骨是其发病机制重要因素之一,关节软骨是由1-2mm厚度胶原纤维、糖蛋白、透明质酸酯聚集而成,当水合作用时就起了垫子样作用,以吸收和分散所承受的负重和机械力量。在生理状况下,关节软骨依靠关节周围及热的收缩及软骨下的骨质来完全上述的任务。肌肉的收缩除带动关节活动外,同时起着橡皮带样作用,吸收了大量传来的冲力,保护了关节。当发生意外(如摔跤)时,因为肌肉对此突发的震动不能及时出现保护性反应而使关节负重加重,可致致害关节损伤,因此肌肉对此突突发的震动不能及时出现保护性反映而使关节负重加重,可致关节损伤。此外,肌肉老化、周围神经病变时,肌肉吸收能量的功能也大大的减弱。协助软骨承负重的另一因素是软骨下呈现网状分布的骨质量,其质地虽较软骨应但比骨皮质软,故具有高度弹性,有利于承受压力。可以看出骨性关节炎多出新在以下两种情况:一是关节软骨、软骨下皮质地、关节周围肌肉有异常时,如老年性退行性变、骨质疏松、炎症、代谢性疾病等:二是关节软骨、关节下骨质、关节周围肌肉虽正常但因承受了过度性压力,如肥胖、外伤等。
     中医药治疗膝骨性关节炎有着丰富的临床经验与独特的优势。随着中医药治疗膝骨性关节炎实验研究的不断深入,对于中医药治疗膝关节炎作用机制的认识,已经从简单的组织形态学分析发展到免疫组织化学、分子生物学等多学科、多层次、多环节的认识。近年来,各种实验研究发现中医药对膝骨性关节炎的影响主要表现在膝骨性关节炎的组织形态学、细胞因子、骨内压、氧自由基等方面。
     KOA的诊断通常是依靠临床表现和放射线检查。其简单的诊断依据是
     1、症状:
     ①疼痛:运动时疼痛主要由机械性或肌腱、韧带接头病所致;休息时疼痛为炎症所致。夜间痛提示骨内压增高,为病情严重和预后不良指征。
     ②僵硬:见于关节不活动之后,但一般持续时间不长。
     ③其他症状如关节肿胀、畸形和关节弹响等。
     2、体征:关节活动响声,骨肥大,不同程度的滑膜炎可致压痛,腱反射异常,肌无力等。严重病例可见功能障碍甚至残废。
     3、观察病人行走、弯腰和进行日常活动的能力。
     4、影象学检查:包括X线、CT和MRI检查。
     5、其他检查:血液检查、关节液检查和关节镜检查等。
     然而,在KOA的早期并不能通过放射线检查发现关节软骨的变化,因为在放射线检查能够发现软骨有改变之前,软骨一定在分子代谢和超微结构上发生了非常显著的变化。
     在原发性KOA的临床研究和实验研究中虽然作出了很多努力,研究表明关节滑膜和关节软骨在原发性KOA发病中起主导作用,但是其发病机制仍然不十分明了,目前多采取手术和对症治疗为主。
     研究目的
     本项研究以关节软骨为研究对象,目的在于通过全基因组基因谱的表达,研究与本病相关的全部差异表达基因,从而进一步探讨软骨差异表达基因与本病的相关性,寻找治疗本病的新靶点和新方法。同时,对部分差异基因进行复孔的实时定量PCR检测,进一步验证所获得的差异基因在原发性KOA病理过程中的意义。
     研究方法
     材料
     1、本研究共采集16例人膝关节软骨样本进行实验。根据纳入标准及排除标准,原发性KOA病人12例,实验用软骨全部在膝关节镜手术和人工膝关节置换术中获得。并根据Kellgren和Laurence放射学分级标准,疾病组将每4个病人的软骨样本分为一组,分为轻(R2)、中(R3)、重(R4)三组;将4例健康人的膝关节软骨样本为健康组(RB1)。
     方法
     1、对上述16例软骨样本分别进行全基因组芯片分析,在每张芯片上所拥有的40000个点上检测出16例样本所共同拥有的基因表达。
     2、按照预先的分组,在共有基因范围内,对每个组内每个对应基因运算其均量,将每组样本转变为一个个体(R2、R3、R4、RB1四组),进行组问比较。
     3、RNA样品制备
     (1)两相分离
     (2)RNA沉淀
     (3)RNA清洗
     (4)重新溶解RNA沉淀
     (5)RNA质量检测
     4、aRNA样品标记和合成
     (1)cDNA合成
     (2)cDNA第二链合成
     (3)aRNA合成
     (4)aRNA纯化
     (5)aa-UTP aRNA间接标记
     (6)质量控制
     5、芯片预杂交
     6、杂交
     7、洗片
     8、结果扫描,数据读取
     9、合成的cDNA用于实时定量PCR
     10、进行Realtime PCR反应
     研究结果
     1、通过本次实验,在16例样本共有基因范围内,鉴定出很多差异表达的基因,而具有统计学意义的差异基因共70个,其中:上调3倍以上的基因46个,其中已知基因28个,未知基因18个。已知基因中,上调4倍以上的基因25个,上调5倍以上的基因15个,上调6倍以上的基因11个,上调7倍以上的基因8个,上调8倍以上的基因3个:下调3倍以上的基因24个,其中已知基因16个,未知基因8个。已知基因中,下调4倍以上的基因11个,下调5倍以上的基因8个,下调6倍以上的基因6个,下调7倍以上的基因6个,下调8倍以上的基因2个。
     2、上调3倍以上的差异基因包括:参与软骨分解代谢的基因及具有免疫功能的基因。
     3、下调3倍以上的差异基因包括:参与软骨合成代谢的基因及具有信息传递功能的基因。
     4、在70个差异表达基因中任意选定10个差异基因,又进行了复孔的PCR实时定量检测,通过三次的重复实验,三次的结果经统计学处理,P<0.001,有显著差异。
     5、R2与R3、R3与R4、R2与R4比较发现,上调或下调3倍以上差异基因在骨性关节炎病变过程中无明显差异,与病变轻重无关。
     结论
     1、原发性膝关节骨性关节炎的发生与关节软骨中的差异表达基因有相关性。
     2、原发性膝关节骨性关节炎的病变程度与关节软骨中的差异表达基因无关。
Osteoarthritis of the knee(KOA) with age is a significant increase in the incidence of degenerative joint disease,joint pain and the elderly are the main reasons for disability. According to the World Health Organization statistics,osteoarthritis prevalence rate in women in the fourth.Increases with age,the prevalence rate rising rapidly,more than 65-year-old more than 50%of people have osteoarthritis of the performance of X-ray film.It's main change is the surface of articular cartilage degeneration and secondary hyperplasia of the bone.The main performance and activities of joint pain is not flexible, X-ray manifestations of joint space narrowing,subchondral bone density,bone fracture, there is sclerosis and cystic change.Joint edge lip hyperplasia.The latter end of the deformation of bone,articular surface uneven.Off articular cartilage,bone fragments into the joints,the formation of intra-articular loose bodies.
     KOA etiology can be divided into primary and secondary KOA,primary KOA, refers to the current method of examination of all the bone unable to cause arthritis, osteoarthritis is usually referred to fall into this category;secondary KOA is the other cause or basis of disease,-induced lesions,such as trauma,rheumatoid arthritis, neurological and endocrine diseases.This type of lesions of osteoarthritis more limited, not associated with Heberden nodules.Repeated strain of the crowd so that the joints suffering from osteoarthritis is high-risk groups,such as foundry workers,miners and bus drivers.But for long-distance train are not suffering from this disease in high-risk groups.Obesity is a major factor in osteoarthritis,but the evidence is not sufficient.In accordance with the KOA site can be divided into focal and generalized KOA,in accordance with whether there are clinical symptoms KOA can be divided into asymptomatic and symptomatic KOA.Encountered in clinical work KOA are symptomatic KOA.Mainly against articular cartilage,bone and synovial tissues,leading to joint pain,deformity and dysfunction,thus affecting the activities of patients.Under normal circumstances,very little friction between the joints will not cause wear and tear, unless the excessive use of or injury.Caused by osteoarthritis is the most likely cause of the abnormal synthesis of cartilage components,such as collagen(a tough,fibrous connective tissue protein) and mucin(a substance produced flexible cartilage) anomalies In addition,the growth of cartilage while strong,but thin,its surface is prone to rupture. Joints over the edge of the bone growth,can see and touch the formation of the mass (known as osteophyte).Osteopbyte caused by uneven articular surface,interfere with the normal function of the joints,causing pain.
     Articular cartilage from disease onset,affects the entire joint structure,including the subchondral bone,ligaments,synovial membrane,joint capsule and muscles,the ultimate result of all the loss of articular cartilage leading to joint deformity and loss of function of a disease.
     Articular cartilage is an important factor in the pathogenesis of the articular cartilage is a 1-2mm thickness of collagen fibers,glycoproteins,hyaluronic acid ester gathered together,when the hydration on a mat-like role in the absorption and dispersion the burden of weight-bearing and mechanical strength.In physiological conditions,relying on the articular cartilage and thermal contraction of the surrounding subchondral bone and to complete the above tasks.In addition to stimulate muscle contraction joint activities,at the same time plays the role of rubber band-like, absorbing a great deal of momentum from the protection of the joints.When an accident occurs(eg,wrestling),because this sudden shock the muscles can not react in time of emergence of protective weight-bearing joints increased virulence may be caused by joint injury,so this sudden burst of muscle vibration protection can not be there in time to reflect heavier load of the joints can be caused by joint injury.In addition,muscle aging,peripheral neuropathy,the muscle function of energy absorption also decreased significantly.Weight-bearing cartilage for the assistance of another factor is the network showing the distribution of subchondral bone quality,its texture,although more cartilage than bone cortex should be soft,it has a high degree of flexibility will help to bear the pressure.Osteoarthritis can be seen more new in the following two situations: First,articular cartilage,subchondral cortex and abnormal muscle around the joints, such as age-related degeneration,osteoporosis,inflammation,metabolic diseases,such as:The second is the articular cartilage of the joints under the bone,the muscles around the joints,although subject to normal due to excessive pressure,such as obesity,trauma, etc.
     Chinese medicine treatment of knee osteoarthritis has a wealth of clinical experience and unique strengths.With the traditional Chinese medicine treatment of knee osteoarthritis Experimental study on the deepening of Chinese medicine for the treatment of knee arthritis awareness of the role of the mechanism,the organization has changed from simple morphological analysis of the development of immunohistochemistry,molecular biology,such as multi-disciplinary,multi-level, multi-session awareness.In recent years,a variety of experimental study found that traditional Chinese medicine for knee osteoarthritis mainly reflected the impact of knee osteoarthritis in the organization of morphology,cell factor,bone pressure,oxygen free radicals and so on.
     KOA diagnosis usually relies on clinical manifestations and radiological examination.Its diagnosis is based on simple.
     1.Symptoms:
     ①pain:pain during exercise or by mechanical tendon,ligament caused by joint disease;rest for the pain caused by inflammation.Night pain prompted increased intraosseous pressure,in order to be in a serious condition and poor prognosis indications.
     ②Rigid:in the joint after inactivity,it is generally not a long duration.③Other symptoms such as joint swelling,deformity and joint ring,such as shells.
     2.Signs:the sound of joint,bone hypertrophy,various degrees of synovitis can be caused by tenderness,abnormal tendon reflexes,such as myasthenia gravis.Serious cases of dysfunction or disability can be seen.
     3.To observe the patient walking,bending and the ability to carry out daily activities.
     4.Imaging examination:including X-ray,CT and MRI examination.
     5.Other tests:blood test,examination and synovial fluid,such as arthroscopy.
     However,in the early and could not KOA radiological examination revealed the changes in articular cartilage,as can be found in the radiographic changes of cartilage prior to a certain cartilage metabolism and ultrastructure in the elements have taken place in very significant changes.
     KOA in primary clinical research and experimental studies although many efforts have been made,the study shows that articular cartilage and synovium in the pathogenesis of primary KOA play a leading role,but its pathogenesis is still not very clear,the current operations and take more symptomatic therapy.
     Objective
     Articular cartilage in the study subjects for the purpose of the adoption of whole-genome gene expression,research and all the disease-related differences in gene expression,thus further explore differentially expressed genes in the cartilage and the relevance of this disease,for treatment of this disease new target and new methods.At the same time,some differences in gene-hole complex real-time quantitative PCR,to further verify the differences in access to primary KOA gene in pathological significance in the process.
     Methods
     Material
     According to addition and exclusion standards,12 patients with OA were performed,and OA cartilage of the knee joint of humans was obtained at the time of arthroscopic surgery and total knee replacement.According to Kellgren and Laurence radiology classification standards 4 patients became a group,then mild(R2) and moderate(R3) and severe late-stage OA groups(R4) appeared.In addition,4 normal cartilage of the knee joint samples became RBl group.
     Methods
     1.All the 16 samples were performed the genome-wide analysis of chips,each chip has 40,000 point samples detected 16 cases of co-owned by the gene expression.
     2.According to the foregoing groups,the genes within each group were corresponding calculated the mean,each group was considered as a entirety (R2,R3,R4,RBl four groups),comparing among the four groups.
     3.RNA sample preparation
     (1) two-dimensional separation
     (2) PNA praecipitatum
     (3) RNA emundation
     (4) again dissolve RNA praecipitatum
     (5) RNA mass detection
     4.aRNA sample symbol and synthesis
     (1) cDNA synthesis
     (2) second-strand of cDNA synthesis
     (3) aRNA synthesis
     (4) aRNA depuration
     (5) aa-UTP aRNA indirect labelling
     (6) quality control
     5.Chip prehybridization
     6.Hybridisation
     7.Chip emundation
     8.Result scanning,data reading
     9.Synthetical cDNA were used to real time quantitative polymerase chain reaction
     10.Performing real time quantitative polymerase chain reaction Results
     1.In this experiment,among the 41000 genes,many differential expression genes were identified,and 70 genes showed statistical significance,of which: 46 genes were up-regulation 3-fold,thereinto 28 known genes and 18 unknown genes,in known genes,25 genes were up-regulation 4-fold,15 genes were up-regulation 5-fold,11 genes were up-regulation 6-fold, 8 genes were up-regulation 7-fold,3 genes were up-regulation 8-fold;24 genes were down-regulation 3-fold,thereinto 16 known genes and 8 unknown genes,in known genes,11 genes were down-regulation 4-fold,8 genes were down-regulation 5-fold,6 genes were down-regulation 6-fold, 6 genes were down-regulation 7-fold,2 genes were down-regulation 8-fold.
     2.More than up-regulation 3-fold of difference genes include:participating gene of cartilage's catabolism and gene with immunologic function.
     3.More than down-regulation 3-fold of difference genes include: participating gene of cartilage's anabolism and gene with information transfer function.
     4.In 70 differentially expressed genes in any differences in the selected 10 genes Were optional selected to perform real time quantitative polymerase chain reaction,through three times repetitive experiments,we miraculously observed the same results of the experiments.Through the statistical treatment, P values less than 0.01,There are significant differences.
     5、During R2 and R3,R3 and R4,R2 and R4 comparison,up-regulation or down-regulation than 3-fold difference in gene expression in the course of osteoarthritis lesions in no significant difference has nothing to do with disease severity.
     Conclusion
     1.KOA's occurance is relate to differentially expressed genes of articular cartilage
     2.KOA's pathological changes is irrelevance with differentially expressed genes of articular cartilage
引文
[1]国家中医药管理局.中医病证诊断疗效标准[s].南京:南京大学出版社,1999:33.
    [2]殷惠芬,王式鲁,毕荣修.中药复方治疗实验性膝骨性关节炎的分子生物学机制研究[J].山东中医药大学学报,2006,30(4):327-328
    [3]邵敏,牛维,黄杰文.补肾活血中药促进体外培养软骨细胞增殖和蛋白质合成的作用[J].中国临床康复,2006,10(19):50-52
    [4]魏玉玲,刘营杰,梁克玉.消痹灵治疗骨性关节炎的机制探讨[J].现代康复,2001,5(4):64-65.
    [5]潘浩,胡庆丰,李雄峰等.补肾壮筋汤对兔早期实验性骨关节炎软骨细胞凋亡及PCNA表达的影响[J].中国中医骨伤科杂.2004,12(4):16-19.
    [6]郭礼跃,胡慧华,米健国.古方稀莶丸对膝骨性关节炎模型家兔关节液中L21β、TNF2α含量及关节软骨细胞形态学的影响[J].中国骨伤,2006,19(6):377-378.
    [7]蔡余力,李刚,颜冰等.补肾壮骨胶囊治疗膝关节骨性关节炎的实验研究[J].中医正骨,2006,18(10):1-4.
    [8]安莉萍,卫荣,魏晓丽等.益肾通痹方对膝关节骨性关节炎兔血清和膝关节腔液中炎性细胞因子和一氧化氮含量的影响[J].中国临床康复,2006,10(15):79-81.
    [9]杨平林,刘德玉,贺西京等.补肾活血中药对膝骨性关节炎家兔血清、滑膜及关节软骨一氧化氮水平的影响[J].中国骨伤,2003,16(11):667-669.
    [10]马建兵,刘德玉,李堪印等.中药对家兔实验性膝关节骨性关节炎氧自由基代谢的影响[J].中医正骨,2000,12(1):8-9.
    [11]韩崑,熊昌源.三联疗法对兔膝骨关节炎氧自由基代谢的影响[J].湖北中医杂志,2006.28(3):9-10.
    [12]邵敏.补肾活血中药对体外培养软骨细胞SOD、NOS的影响[J].福建中医药,2006,37(4):48-49.
    [13]曹燕明,徐海波,陈基长.骨炎定对鸡膝关节骨性关节炎氧自由基代谢的影响[J].中药新药与临床药理2006,17(3):167-170
    [14]姚啸生,李洪久,宋梅亚等.加味补肾壮筋汤对膝骨性关节炎氧自由基代谢的影响[J].中医正骨,2005,17(9):5-6
    [15]欧志峰.白芥子散治疗膝骨性关节炎的临床研究[J].广西医学,2008,30(6):849-850
    [16]任芳,邹季.丹紫康膝冲剂对家兔实验性膝骨关节炎氧自由基代谢的影响[J].中国中医骨伤科杂志.2008,6(3):39-41
    [17]高铁祥.中药复方胶囊治疗骨性关节炎的实验研究[J].中药材.2002,25(10):729-730
    [18]叶俊星,白书臣,吉璐宏等.骨痛胶囊对日本大耳白兔膝骨内高压和血液流变学作用的实验研究[J].中国中医骨伤科杂志,2007,15(2):45-48
    [19]徐攀峰,苟凌云,何林等.复骨健步片对兔膝关节骨性关节炎组织形态学的实验研究[J].中国中医骨伤科杂志2008,16(9):29-31
    [20袁忠治,李继云,刘刚等.补肾活血中药对兔膝骨性关节炎作用的组织测量学研究[J].现代中西医结合杂志,2003,12(23):2523-2524.
    [21]赵文海,赵长伟,闻辉等.鹿茸多肽对兔骨性关节炎软骨细胞金属蛋白酶mRNA表达的影响[J].中国社区医师,2007,9(24):18
    [22]唐勇,姜杰,孟辉,等.补肾益气活血方对兔实验性膝骨关节炎软骨细胞bFGF2mRNA表达的影响[J].云南中医学院学报,2005,28(4):24.
    [23]何晓红.补肾强筋汤治疗膝关节骨性关节炎60例[J].四川中医.2008,26(9):93-94
    [24]季守贤,包洪,康英.补肾壮骨汤治疗膝关节骨性关节炎42例[J].四川中医,2005,23(12):82。
    [25]董军梅,魏琴.补肾壮骨汤治疗膝骨性关节炎疗效观察[J].长春中医药大学学报,2008,24(4):414-415
    [26]严培军,孙玉明,周福贻.从痰瘀水论治膝关节骨性关节炎176例[J].南京中医药大学学报(自然科学版),2000,16(4):249.
    [27]雷波,刘定安.从瘀血痰湿论治膝关节骨关节病48例临床观察[J].湖南中医杂志,1999,15(2):12-13.
    [28]惠乃华,孟祥奇,姜宏.从痰湿瘀论治膝骨性关节炎的临床观察[J].中医正骨,2007,19(2):12-13.
    [29]吕建国,郑清莲.补肾活血方剂治疗膝关节退行性关节炎165例[J].陕西中医,2006,27(8):949-950.
    [30]王和鸣,李楠.膝骨性关节炎的中医药实验研究进展[J].福建中医学院学报2004,14(6):52-53.
    [31]李煌明.补肾活血健膝汤治疗膝骨性关节炎的临床观察[J].中国厂矿医学,2005,18(6):552.
    [32]冯国军,席占东,郭继芳.自拟活血舒筋洗剂治疗膝关节骨性关节炎150例报道[J].,北京中医,2004,23(6):356-357.
    [33]闻辉,赵文海,李晓春等.膝痛康贴膏治疗膝骨性关节炎临床观察[J].吉林中医药,2008,28(9):664
    [34]张天英.温针、手法加超短波电疗治疗膝关节痛69例[J].按摩与导引,1997,7(6):15-17
    [35]张秀华,曲红伟,孙玉凤.中药离子透入治疗膝关节骨性关节炎36例[J].黑龙江中医药,1998,(3):41-42
    [36]步东南.自拟方内服外敷治疗膝骨性关节炎67例[J].使用中医内科杂志,2008,22(7):45
    [37]杨梦林,华刚,刘守新.中药加针灸治疗膝关节骨性关节炎164例[J].吉林中医药,2007,27(2):41.
    [38]耿学英,丁建中.中药治疗膝关节骨性关节炎临床观察[J],中国康复理论与实践,2006,12(5)
    [39]庞学丰,马晓露.中药内外合治膝骨性关节炎86例[J].陕西中医,2003,24(9):803-804.
    [40]王守东,王守星,李德宪等.骨痹胶囊配骨痹散治疗膝骨性关节炎临床观察[J],中医正骨,2008.20(8):60
    [41]邱贵兴.骨关节流行病学和病因学进展[J].继续医学教育,2005,19(7):68-69
    [42]薛森海,王治伦,杨浩杰.基质金属蛋白酶及细胞因子在骨关节炎发病机制中的研究[J].中国地方病防治杂志,2007,22(6):420-423
    [43]Itoh Y,Nagase H.Matrix metallop roteinases in cancer[J].Essays Biochem,2002,38:21.
    [44]Hojo Y,Ikeda U,TakahashiM,et al.Matrixmetallop rotei2nase-1 exp ression by interaction between monocytes andvascular endothelial cells[J].J Mol Cell Cardiol,2000,32(8):1459.
    [45]李德达,张凯,王毅等.OA患者关节液与血清中金属蛋白酶及抑制剂的检测及临床意义[J].中国骨伤,2002,15(10):580-585.
    [46]吴宏斌,杜靖远,郑启新,等.基质金属蛋白酶21在创伤性骨关节炎软骨及滑膜中的表达[J].中华创伤杂志,2003,19(1):24-26.
    [47]吴宏斌,杜靖远,胡勇,等.兔前交叉韧带切断骨关节炎模型中MMP-1、MMP-13及TIMP-1mRNA表达研究[J].中华风湿病学杂志,2002,6(3):169-173.
    [48]Freemont AJ,Byers RJ,taiwo YO,et al.In situ zymographic localisationof type Ⅱ collagen degrading activity in osteoarthritic human articularcartilage[J].Ann Rheum Dis,1999,58(6):357
    [49]刘志翔,张柳.基质金属蛋白酶和骨关节炎的研究进展[J],华北煤炭医学院学报,2007,9(3):330-332
    [50]娄海容.骨性关节炎研究最新进展(一)[J].现代医院,2008,8(7):4-7
    [51]王毅,刘长明.基质金属蛋白酶与骨关节疾病关系的研究进展[J].中国骨伤,2003,16(3):190-192
    [52]谈志龙,邢国胜,李德达等.细胞因子对关节软骨细胞作用的研究[J].骨与关节损伤杂志2003,18(5):316-318
    [53]滕海,白希壮,周毅等.几种细胞因子在骨关节炎病理生理中的作用[J].解剖科学进展,2004,10(1):76-78
    [54]Mengshol JA,Mix KS,Brinckerhoff CE.Matrix metallop roteinases as therapeutic targets in arthritic diseases[J].Arthritis Rheum,2002,46(1):13-20.
    [55]Goldberg AJ,Lee DA,Bader DL,et al.Autologous chondrocyte implantation.Culture in a TGF-beta-containing medium enhances the reexpression of a chondrocytic phenotype in passaged human chondrocytes in pellet culture[J].J Bone Joint Surg(Br),2005,87(1):128-134.
    [56]田华,Carrie Fang,Paul E.骨形态发生蛋白22对软骨寡聚基质蛋白在软骨细胞内表达的影响[J].北京大学学报(医学版),2003,35(3):317.
    [57]赵东升.一氧化氮在骨关节炎发病中的作用机制[J].现代中西医结合杂志,2008,17(16):2583-2585
    [58]Hashimoto S,Takahashi K,Amiel D,et al.Chondrocyte apoptosisand nitic oxide production during experimentlly induced os2teoarthristis[J].Arthritis Rheum,1998,41:66-74
    [69]Kuhn K Hashimoto S,Lotz M.IL-1 beta protects human chondroeytesFrom CD95-induced apoptosis[J].J Immunol,2000:164(4):2233-2239.
    [60]李美荣,王美美.骨关节炎患者血清和关节液一氧化氮及其合成酶变化的意义[J].安徽医药,2004,9(2);108-109.
    [61]金伟,陈廖斌.生物自由基与骨性关节炎[J].湖北预防医学杂志,2002,13(5):13
    [62]朱杰,魏西秦,张健.氧自由基对人胚软骨细胞DNA及基质成分合成的抑制作用[J].中华外科杂志,1993,31:561-563.
    [63]孙永生,娄思权.骨性关节炎发病分子机制研究进展[J].中国骨与关节损伤杂志,2005,20(8):571-573
    [64]高仰贤,骨性关节炎发病机制的国内研究进展[J].中医正骨,2005,17(4):55-57
    [65]蔡伟平,汤亭亭.骨关节炎的细胞生物学研究进展[J].国外医学.骨科分册,2004,25(1):18-21
    [66]张晓玲,于长隆.骨关节炎基因治疗现状与前景[J].北京大学学报(医学版),2002,34(5):579-584
    [67]Oligino TJ,Yao QP1 Vector systems for gene transfer to joints[J].ClinOrthop,2000,379(suppl):s17-30
    [68]张晓玲,于长隆,毛泽斌等.骨性关节炎的联合基因治疗[J]研究中国运动医学杂志,2006,25(1):5-8
    [69]zhang X,Mao Z,Yu cJ,,et al,JOrop Res,2005,23(1):118-126
    [70]Frisbie DD,Mc wraith CW.Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis.Clin Orthop,2000,379(Suppl):S273-S287.
    [71]Baragi VM,Renkiewicz RR,Qui L,et all Transplantation of adenovi2rally transduced allogeneic chondrocytes into articular cartilage defects invivo[J].Osteoarthritis Cartilage,1997,5:275-282
    [72]裴明,曲绵域,于长隆.阳离子脂质体DOTAP介导报道基因转染骨关节病滑膜细 胞的实验研究[J]1中国运动医学杂志,1999,18(2):106-108
    [73]王瑞,赵建宁.骨性关节炎基因治疗研究进展[J].人民军医,2006,49(8):481-484

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700